3/27
05:00 am
enlay
Enel: Entering A New Growth Phase [Seeking Alpha]
Neutral
Report
Enel: Entering A New Growth Phase [Seeking Alpha]
3/24
02:39 pm
enlay
AGM Statement [Yahoo! Finance]
Low
Report
AGM Statement [Yahoo! Finance]
3/18
09:18 am
enlay
Earnings To Watch: Enel SpA (MIL:ENEL) Reports Q4 2025 Result [Yahoo! Finance]
Low
Report
Earnings To Watch: Enel SpA (MIL:ENEL) Reports Q4 2025 Result [Yahoo! Finance]
3/12
08:44 pm
enlay
How The Enel Chile (SNSE:ENELCHILE) Narrative Is Shifting As Expectations Are Recalibrated [Yahoo! Finance]
Low
Report
How The Enel Chile (SNSE:ENELCHILE) Narrative Is Shifting As Expectations Are Recalibrated [Yahoo! Finance]
3/7
01:43 am
enlay
Enel Chile Partnership With Senapred Puts Climate Resilience In Investor Focus [Yahoo! Finance]
Low
Report
Enel Chile Partnership With Senapred Puts Climate Resilience In Investor Focus [Yahoo! Finance]
3/3
06:18 pm
enlay
Enel Chile S.A. (ENIC) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Enel Chile S.A. (ENIC) Q4 2025 Earnings Call Transcript [Seeking Alpha]
2/27
07:13 am
enlay
Concentrated Solar Power Market Size to Grow USD 30.74 billion by 2035 | Research by SNS Insider [Yahoo! Finance]
Low
Report
Concentrated Solar Power Market Size to Grow USD 30.74 billion by 2035 | Research by SNS Insider [Yahoo! Finance]
2/25
12:31 pm
enlay
Enel announces $63bn investment plan focused on Europe and US [Yahoo! Finance]
Low
Report
Enel announces $63bn investment plan focused on Europe and US [Yahoo! Finance]
2/24
01:14 pm
enlay
Enel (OTCMKTS:ENLAY) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
Enel (OTCMKTS:ENLAY) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
2/7
10:35 am
enlay
Enel: Still A Buy With Balance Sheet Optionality [Seeking Alpha]
Low
Report
Enel: Still A Buy With Balance Sheet Optionality [Seeking Alpha]
2/4
02:04 pm
enlay
Enel (OTCMKTS:ENLAY) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Enel (OTCMKTS:ENLAY) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..